$ACT Allergan Finance LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan Finance LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allergan Finance LLC. Insider overview, share value development, latest insider transactions and email notifications about new events in Allergan Finance LLC for free.
IRS Number: 953872914
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ACT
Company Address: MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY 07054
Phone number: 9092701400
Former name: WATSON PHARMACEUTICALS INC, date of change: 1993-05-13
Former name: Actavis, Inc., date of change: 2013-01-24
Prev close: $299.00
Average Daily Volume: 2,770,570
Days Low: $0.00
Year Low: $202.00
Year High: $318.00
Allergan Finance LLC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2013 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | D | 0.00 | 27,275 | 0 | 0 | 27.3 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | TAYLOR RONALD R | Director | Sell | D | 0.00 | 27,942 | 0 | 0 | 27.9 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | D | 0.00 | 5,441 | 0 | 0 | 5.4 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Sell | D | 0.00 | 1,877 | 0 | 0 | 1.9 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | KLEMA CATHY | Director | Sell | D | 0.00 | 19,608 | 0 | 0 | 19.6 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | HUMMEL ALBERT F | Director | Sell | D | 0.00 | 82,776 | 0 | 0 | 82.8 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Sell | D | 0.00 | 500 | 0 | 0 | 500 to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Sell | D | 0.00 | 12,941 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Sell | D | 0.00 | 25,382 | 0 | 0 | 25.4 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | BODINE CHRIS W | Director | Sell | D | 0.00 | 14,629 | 0 | 0 | 14.6 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | Wilkinson George Fred | Pres-Global Brands& ... | Sell | D | 0.00 | 45,412 | 0 | 0 | 45.4 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | Wilkinson George Fred | Pres-Global Brands& ... | Payment of Exercise | F | 144.00 | 43,429 | 6,253,776 | 45,412 | 88.8 K to 45.4 K (-48.88 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | Wilkinson George Fred | Pres-Global Brands& ... | Grant | A | 0.00 | 39,612 | 0 | 88,841 | 49.2 K to 88.8 K (+80.46 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | Stewart Robert A | Pres-Global Operati ... | Option Exercise | D | 86.86 | 75,000 | 6,514,500 | 0 | |
| Oct 02 2013 | ACT | Actavis, Inc. | Stewart Robert A | Pres-Global Operati ... | Sell | D | 0.00 | 71,252 | 0 | 0 | 71.3 K to 0 (-100.00 %) |